The DOI matches its Crossref record.
Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations
Abstract
Excipient concentrations are critical quality attributes of monoclonal antibody (mAb) drug products and affect their safety and efficacy. In manufacturing processes, mAb products are formulated into the buffer containing the desired excipients using ultrafiltration (UF) and diafiltration (DF). Control of excipient concentrations is a challenge during high concentration UF due to electrostatic interactions which lead to excipient concentration drifts. This challenge is of increasing importance due to the growing preference towards high concentration subcutaneous drug formulations over conventional intravenous formulations in the biotherapeutic industry. Excipient concentrations are currently measured using offline RP-HPLC which is time-consuming and not suited for real time control. We propose a novel process analytical technology (PAT) tool for monitoring and control of mAb and excipients in high concentration UF using Near Infrared Spectroscopy (NIRS). The NIRS is able to monitor concentrations within ±1% for mAb and ±2% for two common excipients, L-histidine and acetate. A Python-based controller uses real time concentration data to deliver concentrated excipient stock solutions to the UF reservoir whenever the excipient concentrations drift out of range. The PAT control system is able to achieve the target formulation without manual intervention or at-line analysis and is well-suited for implementation in mAb manufacturing platforms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been integrated in‐line for the simultaneous monitoring of protein and excipient concentrations in antibody formulations during the UFDF, and the quantification was done in real time, in a few seconds [64].”
From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [64]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 30
- Ahrer, 2006, Effects of ultra-/diafiltration conditions on present aggregates in human immunoglobulin G preparations, J. Membr. Sci., 274, 108, 10.1016/j.memsci.2005.08.018 · DOI
- Annathur, 2010, Ultrafiltration of a highly self-associating protein, J. Membr. Sci., 353, 41, 10.1016/j.memsci.2010.02.027 · DOI
- Arunkumar, 2016, Effect of channel-induced shear on biologics during ultrafiltration/diafiltration (UF/DF), J. Membr. Sci., 514, 671, 10.1016/j.memsci.2016.05.031 · DOI
- Binabaji, 2015, Theoretical analysis of the ultrafiltration behavior of highly concentrated protein solutions, J. Membr. Sci., 494, 216, 10.1016/j.memsci.2015.07.068 · DOI
- Bittner, 2018, Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities, BioDrugs, 32, 425, 10.1007/s40259-018-0295-0 · DOI · Paper page
- Chung, 2003, Feasibility of monitoring acetic acid process using near-infrared spectroscopy, Vib. Spectrosc., 31, 125, 10.1016/S0924-2031(02)00105-4 · DOI
- Davies, 2017, Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial, Lancet Haematol., 4, e272, 10.1016/S2352-3026(17)30078-9 · DOI · Paper page
- Fuerle, 2011, Formulation of the Audze-Eglais uniform Latin hypercube design of experiments for constrained design spaces, Adv. Eng. Softw., 42, 680, 10.1016/j.advengsoft.2011.05.004 · DOI
- Geladi, 1995, An overview of chemometrics applications in near infrared spectrometry, J. Near Infrared Spectrosc., 3, 119, 10.1255/jnirs.63 · DOI
- Hebbi, 2019, High performance liquid chromatography (HPLC) based direct and simultaneous estimation of excipients in biopharmaceutical products, J. Chromatogr. B, 1117, 118, 10.1016/j.jchromb.2019.04.022 · DOI
- Hebbi, 2020, Modeling and prediction of excipient and pH drifts during ultrafiltration/diafiltration of monoclonal antibody biotherapeutic for high concentration formulations, Sep. Purif. Technol., 238, 10.1016/j.seppur.2019.116392 · DOI
- Huang, 2017, Enablement of the direct analysis of excipients in monoclonal antibody formulations through the incorporation of a wide pore C18 protein trap with hydrophilic interaction liquid chromatography, J. Chromatogr. B, 1068, 131, 10.1016/j.jchromb.2017.10.034 · DOI
- Huffman, 2014, UV-Vis based determination of protein concentration: Validating and implementing slope measurements using variable pathlength technology, Bioprocess Int., 12, 66
- Hung, 2016, High concentration tangential flow ultrafiltration of stable monoclonal antibody solutions with low viscosities, J. Membr. Sci., 508, 113, 10.1016/j.memsci.2016.02.031 · DOI
- Le Basle, 2020, Physicochemical stability of monoclonal antibodies: a review, J. Pharm. Sci., 109, 169, 10.1016/j.xphs.2019.08.009 · DOI
- Lehr, 2015, Evaluation of a variable-pathlength spectrophotometer: a comparable instrument for determining protein concentration, BioProcess Int, 13
- Levenstein, 1996, Utilization of the Donnan effect for improving electrolyte separation with nanofiltration membranes, J. Membr. Sci., 116, 77, 10.1016/0376-7388(96)00029-4 · DOI
- Miao, 2009, Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody, Biotechnol. Prog., 25, 964, 10.1002/btpr.168 · DOI
- Molek, 2010, Effect of electrostatic interactions on transmission of PEGylated proteins through charged ultrafiltration membranes, J. Membr. Sci., 353, 60, 10.1016/j.memsci.2010.02.031 · DOI
- Palou, 2012, Determination of drug, excipients and coating distribution in pharmaceutical tablets using NIR-CI, J. Pharm. Anal., 2, 90, 10.1016/j.jpha.2011.11.003 · DOI
- Pasquini, 2003, Near infrared spectroscopy: fundamentals, practical aspects and analytical applications, J. Braz. Chem. Soc., 14, 198, 10.1590/S0103-50532003000200006 · DOI
- Rosenberg, 2009, Ultrafiltration concentration of monoclonal antibody solutions: Development of an optimized method minimizing aggregation, J. Membr. Sci., 342, 50, 10.1016/j.memsci.2009.06.028 · DOI
- Sánchez, 2019, Comparative cost analysis of intravenous and subcutaneous administration of rituximab in lymphoma patients, ClinicoEcon. Outcomes Res.: CEOR, 11, 695, 10.2147/CEOR.S212257 · DOI
- Shire, 2009, Formulation and manufacturability of biologics, Curr. Opin. Biotechnol., 20, 708, 10.1016/j.copbio.2009.10.006 · DOI
- Steele, 2014, Accounting for the Donnan effect in diafiltration optimization for high-concentration UFDF applications, BioProcess. Int., 12, 50
- Stoner, 2004, Protein− solute interactions affect the outcome of ultrafiltration/diafiltration operations, J. Pharm. Sci., 93, 2332, 10.1002/jps.20145 · DOI
- Teeters, 2011, Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies, Biotechnol. Bioeng., 108, 1338, 10.1002/bit.23067 · DOI
- Turner, 2018, Challenges and opportunities for the subcutaneous delivery of therapeutic proteins, J. Pharm. Sci., 107, 1247, 10.1016/j.xphs.2018.01.007 · DOI
- van Reis, 2007, Bioprocess membrane technology, J. Membr. Sci., 297, 16, 10.1016/j.memsci.2007.02.045 · DOI
- Wahl, 2014, PAT for tableting: inline monitoring of API and excipients via NIR spectroscopy, Eur. J. Pharm. Biopharm., 87, 271, 10.1016/j.ejpb.2014.03.021 · DOI
Cited by
Sorted by citations
Current PAT Landscape in the Downstream Processing of Biopharmaceuticals
Sathiyapriyan, P., Mukherjee, S., Vogel, T., Essen, L., Boerema, D., Vey, M., & Kalina, U. (2025) · Analytical Science Advances · doi:10.1002/ansa.70013 · Cited by 45
Metadata
- Authors
- Thakur, G., Hebbi, V., & Rathore, A. S.
- Affiliations
- Indian Institute of Technology Delhi (IN)
- Corresponding author
- Rathore, Anurag S.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 600
- Pages
- 120456
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W3134015480
- Cited by
- 31
- References
- 0
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 7 · 2023: 5 · 2022: 2 · 2021: 3
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Journal of Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology Ministry of Science and Technology
- Department of Science and Technology
- Ministry of Human Resource Development (21\u2013105/2015\u2010TS.II/TC)
- Tata Consultancy Services Ltd
- Council of Scientific and Industrial Research, India (09/086(1225)/2015-EMRI)
- Topics
- Physical Sciences › Chemistry › Analytical Chemistry › Spectroscopy and Chemometric Analyses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
- Keywords
- near-infrared spectroscopy, process analytical technology, ultrafiltration, diafiltration, monoclonal antibodies, real-time process control, histidine, acetate, electrostatic interactions, biopharmaceutical manufacturing
- MeSH terms
- Antibodies, Monoclonal, Excipients, Technology, Ultrafiltration, Spectroscopy, Near-Infrared
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations. https://app.cochat.ai/papers/10.1016/j.ijpharm.2021.120456
- The paper
- Thakur, G., Hebbi, V., & Rathore, A. S. (2021). Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2021.120456